These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24602898)

  • 1. Secondary hematoma expansion in intracerebral hemorrhage during rivaroxaban therapy.
    Purrucker JC; Capper D; Behrens L; Veltkamp R
    Am J Emerg Med; 2014 Aug; 32(8):947.e3-5. PubMed ID: 24602898
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemostatic therapy in experimental intracerebral hemorrhage associated with rivaroxaban.
    Zhou W; Zorn M; Nawroth P; Bütehorn U; Perzborn E; Heitmeier S; Veltkamp R
    Stroke; 2013 Mar; 44(3):771-8. PubMed ID: 23339956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rivaroxaban does not increase hemorrhage after thrombolysis in experimental ischemic stroke.
    Ploen R; Sun L; Zhou W; Heitmeier S; Zorn M; Jenetzky E; Veltkamp R
    J Cereb Blood Flow Metab; 2014 Mar; 34(3):495-501. PubMed ID: 24346690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral hemorrhage under rivaroxaban.
    Stöllberger C; Zuntner G; Bastovansky A; Finsterer J
    Int J Cardiol; 2013 Sep; 167(6):e179-81. PubMed ID: 23651821
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis.
    Harenberg J; Marx S; Diener HC; Lip GY; Marder VJ; Wehling M; Weiss C
    Int Angiol; 2012 Aug; 31(4):330-9. PubMed ID: 22801398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rivaroxaban at least as effective as marcumar in stroke prevention].
    Aumiller J
    MMW Fortschr Med; 2010 Dec; 152(48):14. PubMed ID: 21222327
    [No Abstract]   [Full Text] [Related]  

  • 7. Summaries for patients. Rivaroxaban in patients transitioned from vitamin K antagonist therapy.
    Ann Intern Med; 2013 Jun; 158(12):I-28. PubMed ID: 23778921
    [No Abstract]   [Full Text] [Related]  

  • 8. Dabigatran-related intracerebral hemorrhage resulting in hematoma expansion.
    Simonsen CZ; Steiner T; Tietze A; Damgaard D
    J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):e133-4. PubMed ID: 24103671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New alternative to warfarin may help reduce stroke risk in patients with AF.
    Mitka M
    JAMA; 2011 Jan; 305(1):25-6. PubMed ID: 21205957
    [No Abstract]   [Full Text] [Related]  

  • 10. [Advances in venous thromboembolism].
    Qin L; Lu WX
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 May; 36(5):372-4. PubMed ID: 24047815
    [No Abstract]   [Full Text] [Related]  

  • 11. Rivaroxaban for stroke prevention in atrial fibrillation: a critical review of the ROCKET AF trial.
    Paikin JS; Manolakos JJ; Eikelboom JW
    Expert Rev Cardiovasc Ther; 2012 Aug; 10(8):965-72. PubMed ID: 23030284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneus splenic rupture in a patient treated with rivaroxaban.
    Gonzva J; Patricelli R; Lignac D
    Am J Emerg Med; 2014 Aug; 32(8):950.e3. PubMed ID: 24612597
    [No Abstract]   [Full Text] [Related]  

  • 13. Reconsideration of anticoagulant therapy in Japanese patients with atrial fibrillation and moderate renal impairment.
    Shiga T
    Circ J; 2013; 77(3):596-7. PubMed ID: 23363645
    [No Abstract]   [Full Text] [Related]  

  • 14. Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.
    Lip GY; Larsen TB; Skjøth F; Rasmussen LH
    J Am Coll Cardiol; 2012 Aug; 60(8):738-46. PubMed ID: 22575324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of intracerebral hemorrhage during rivaroxaban treatment: comparison with those during warfarin.
    Hagii J; Tomita H; Metoki N; Saito S; Shiroto H; Hitomi H; Kamada T; Seino S; Takahashi K; Baba Y; Sasaki S; Uchizawa T; Iwata M; Matsumoto S; Osanai T; Yasujima M; Okumura K
    Stroke; 2014 Sep; 45(9):2805-7. PubMed ID: 25082810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rıvaroxaban-induced severe diffuse ıntracerebral hemorrhage.
    Çalışkan F; Akdemir HU; Nurata H; Akdemir N; Başara G; Yavuz Y
    Am J Emerg Med; 2015 Mar; 33(3):475.e1-5. PubMed ID: 25218622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rivaroxaban and stroke prevention in patients with atrial fibrillation: new evidence.
    Martínez-Rubio A; Dan GA; Kaski JC
    Expert Rev Cardiovasc Ther; 2014 Aug; 12(8):933-47. PubMed ID: 24948333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of pulmonary embolism. Rivaroxaban is superior to standard therapy].
    Einecke D
    MMW Fortschr Med; 2012 Apr; 154(7):24. PubMed ID: 22558862
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical outcomes with rivaroxaban in patients transitioned from vitamin K antagonist therapy: a subgroup analysis of a randomized trial.
    Mahaffey KW; Wojdyla D; Hankey GJ; White HD; Nessel CC; Piccini JP; Patel MR; Berkowitz SD; Becker RC; Halperin JL; Singer DE; Califf RM; Fox KA; Breithardt G; Hacke W
    Ann Intern Med; 2013 Jun; 158(12):861-8. PubMed ID: 23778903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rivaroxaban for thromboprophylaxis.
    Lotke PA
    N Engl J Med; 2008 Nov; 359(20):2174; author reply 2175-6. PubMed ID: 19009675
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.